The company claims its semaglutide drops, which are applied under the tongue, contain the same active ingredient found in Ozempic and Wegovy and provide the powerful benefits of GLP-1 without injections. EllieMD further touts, under a benefits tab on the drops product page, that the drops offer prescription appetite suppression and are scientifically backed to help users lose weight, adding that the drops can help to lower blood sugar levels and potentially reduce the risk factors associated with conditions like type 2 diabetes, high blood pressure and cardiovascular disease, which are often linked to diabetes. Meanwhile, a recent EllieMD Instagram post boasts about the cardiovascular benefits of its GLP-1 medication, including decreased risk of cardiovascular disease, heart attack and stroke
Review your current semaglutide dosage or tirzepatide dosage in units before your trip
The 0.01 mg/kg dose that showed consistent effects in rats translates to approximately 0.0016 to 0.004 mg/kg in humans, which works out to roughly 0.112 to 0.28 mg for a 154-pound person
Retatrutide, by contrast, is still investigational and only available through clinical trials
Employers have other opportunities to rein in hidden costs and protect patient choice
.png)